Related Experiment Video
Updated: Jun 10, 2025
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
A Toolkit to Facilitate the Selection and Measurement of Health Equity Indicators for Cardiovascular Disease
Dorothy Wei1, Simone McPherson2, Refilwe Moeti3
1Deloitte Consulting, LLC, Atlanta, Georgia.
Insights
This study introduces the Health Equity Indicators for Cardiovascular Disease (HEI for CVD) Toolkit, offering metrics and guidance to address health inequities in cardiovascular disease (CVD) prevention and care.
Area of Science:
- Public Health
- Health Equity Research
- Cardiovascular Disease Epidemiology
Background:
- Cardiovascular disease (CVD) is a leading cause of death in the US, significantly impacted by social determinants of health.
- CVD disproportionately affects marginalized populations, yet professionals lack tools to address these inequities.
- Existing approaches often fail to adequately measure or address the social drivers of CVD disparities.
Purpose of the Study:
- To introduce the Health Equity Indicators for Cardiovascular Disease (HEI for CVD) Toolkit.
- To provide metrics, measurement guidance, and resources for understanding and addressing CVD health inequities.
- To support health care and public health professionals in collecting and utilizing data on social determinants of health.
Main Methods:
- Conducted literature scans to identify key themes in CVD health inequities.
- Engaged subject matter experts in health equity and cardiovascular disease.
- Performed pilot studies to assess the feasibility of data collection and analysis on social determinants of health.
Main Results:
- Developed a comprehensive toolkit including a conceptual framework, health equity indicators, and measurement guidance.
- The toolkit offers resources for understanding CVD drivers of inequity, assessing progress, and evaluating interventions.
- Pilot studies confirmed the feasibility of gathering and analyzing relevant social determinants of health data.
Conclusions:
- The HEI for CVD Toolkit empowers users to understand and address the drivers of cardiovascular disease inequities.
- It facilitates the assessment of progress and evaluation of interventions aimed at reducing CVD disparities.
- The toolkit provides a practical framework for integrating health equity measurement into CVD prevention and care efforts.
Abstract:
Cardiovascular disease (CVD) is the leading cause of illness and death in the US and is substantially affected by social determinants of health, such as social, economic, and environmental factors. CVD disproportionately affects groups that have been economically and socially marginalized, yet health care and public health professionals often lack tools for collecting and using data to understand and address CVD inequities among their populations of focus. The Health Equity Indicators for Cardiovascular Disease Toolkit (HEI for CVD Toolkit) seeks to address this gap by providing metrics, measurement guidance, and resources to support users collecting, measuring, and analyzing data relevant to their CVD work. The toolkit includes a conceptual framework (a visual model for understanding health inequities in CVD); a comprehensive list of health equity indicators (metrics of inequities that influence CVD prevention, care, and management); guidance in definitions, measures, and data sources; lessons learned and examples of HEI implementation; and other resources to support health equity measurement. To develop this toolkit, we performed literature scans to identify primary topics and themes relevant to addressing inequities in CVD, engaged with subject matter experts in health equity and CVD, and conducted pilot studies to understand the feasibility of gathering and analyzing data on the social determinants of health in various settings. This comprehensive development process resulted in a toolkit that can help users understand the drivers of inequities in their communities or patient populations, assess progress, evaluate intervention outcomes, and guide actions to address CVD disparities.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Related Concept Videos
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:29Bias in Epidemiological Studies
01:29Assessment of the Cardiovascular System II: Inspection
Head and Neck
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:20Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...